Frontiers in antibiotic alternatives for Clostridioides difficile infection

doi:10.3748/wjg.v27.i42.7210

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 42

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10335)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

817

WORD

125

HTML

6981

Figures (1-1)

310

Tables (1-3)

538

Sum=8771

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

266

Download

364

Sum=630

Publishing Process of This Article

Item

Count

Browse

387

Download

547

Sum=934

Nov 14, 2021 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Frontier

World J Gastroenterol. Nov 14, 2021; 27(42): 7210-7232
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7210

Table 1 Representatives of anti-Clostridioides difficile chemical clusters from reported literature

Cluster No.	Compound class
21	Antifungal imidazoles
42	Metronidazole and its derivatives
61	Benzalkonium cationic surfactants
88–97	β-lactams
98–99	Tetracycline and its derivatives
123	Aminoglycosides

Citation: Phanchana M, Harnvoravongchai P, Wongkuna S, Phetruen T, Phothichaisri W, Panturat S, Pipatthana M, Charoensutthivarakul S, Chankhamhaengdecha S, Janvilisri T. Frontiers in antibiotic alternatives for Clostridioides difficile infection. World J Gastroenterol 2021; 27(42): 7210-7232
URL: https://www.wjgnet.com/1007-9327/full/v27/i42/7210.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i42.7210